Glycyrrhetinic Acid and Autocrine Motility Factor Converge on G6PD Suppression, Oxidative Stress, and Drug Retention to Impair Pancreatic Ductal Adenocarcinoma Cell Growth
Anticancer Research · 2026-08 · 46 (8) · 4301-4309
DOI: 10.21873/anticanres.18288 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 29.07.2026. Verfasst von Na Young Park und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Food Science and Technology, Daegu Catholic University, Gyeongsan, Republic of Korea. Hauptthemen laut MEDLINE: Glycyrrhetinic Acid, Oxidative Stress, Glucosephosphate Dehydrogenase, Carcinoma, Pancreatic Ductal.
Abstract (Originalsprache)
BACKGROUND/AIM: Pancreatic ductal adenocarcinoma (PDAC) remains one of the most lethal malignancies, driven by chemoresistance and metabolic reprogramming centered on glucose-6-phosphate dehydrogenase (G6PD)-dependent pentose phosphate pathway activity. Exogenously administered autocrine motility factor (AMF) suppresses G6PD at transcriptional and protein levels, elevating intracellular reactive oxygen species (ROS) to cytostatic thresholds. Glycyrrhetinic acid (GA), a bioactive triterpenoid from licorice root, amplifies oxidative stress through mitochondrial membrane disruption, while concurrently downregulating multidrug resistance-associated ABC transporters. MATERIALS AND METHODS: Three PDAC cell lines were treated with AMF variants and GA. Cell viability was assessed by MTT assay and clonogenic survival assays. Mechanistic endpoints included DCFDA fluorescence, Western blotting, RT-qPCR, and doxorubicin/Hoechst 33342 fluorescence for drug retention analysis. RESULTS: Among eight distinct AMF variants, HG-AMF demonstrated the greatest cytotoxic potency both alone and in combination with GA. HG-AMF suppressed G6PD mRNA and protein expression, inducing sustained ROS accumulation confirmed by DCFDA fluorescence. Co-treatment with GA produced enhanced ROS generation, clonogenic suppression, decreased mitochondrial membrane potential, and impaired drug efflux. CONCLUSION: HG-AMF and GA converge on G6PD-dependent metabolism and chemoresistance pathways, providing a rational basis for their combined application in PDAC therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Food Science and Technology, Daegu Catholic University, Gyeongsan, Republic of Korea.
- Department of Health Management, Daegu Catholic University, Gyeongsan, Republic of Korea.
- Department of Cosmetic Science, Kyungsung University, Busan, Republic of Korea; sgkim@ks.ac.kr.
- Industry Academic Cooperation Foundation, Daegu Haany University, Gyeongsan, Republic of Korea jhlee86@dhu.ac.kr.
Zitieren
APA
Park, N. Y., Kim, C., Park, H. S., Kim, S. G., & Lee, J. (2026). Glycyrrhetinic Acid and Autocrine Motility Factor Converge on G6PD Suppression, Oxidative Stress, and Drug Retention to Impair Pancreatic Ductal Adenocarcinoma Cell Growth. Anticancer Research, 46(8), 4301-4309. https://doi.org/10.21873/anticanres.18288
Vancouver
Park NY, Kim C, Park HS, Kim SG, Lee J. Glycyrrhetinic Acid and Autocrine Motility Factor Converge on G6PD Suppression, Oxidative Stress, and Drug Retention to Impair Pancreatic Ductal Adenocarcinoma Cell Growth. Anticancer Research. 2026;46(8):4301-4309. doi:10.21873/anticanres.18288
BibTeX
@article{Park2026,
author = {Park, Na Young and Kim, Changyul and Park, Hee Sung and Kim, Se Gie and Lee, Jihye},
title = {Glycyrrhetinic Acid and Autocrine Motility Factor Converge on G6PD Suppression, Oxidative Stress, and Drug Retention to Impair Pancreatic Ductal Adenocarcinoma Cell Growth},
journal = {Anticancer Research},
year = {2026},
volume = {46},
number = {8},
pages = {4301--4309},
doi = {10.21873/anticanres.18288}
}
EUVIMED